Rui Manuel Ferreira Henrique - Nanotechnology

Author Information

Rui Manuel Ferreira Henrique is affiliated with the Cancer Biology & Epigenetics Group at the Research Center of IPO Porto (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto). He is also part of the Porto Comprehensive Cancer Center - Raquel Seruca (Porto.CCC) & CI-IPOP@RISE (Health Research Network), located at Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.

Research Contributions

Rui Manuel Ferreira Henrique has made significant contributions to cancer research, particularly in the areas of epigenetics, metabolomics, and biomarker identification. His most recent work includes studies on the modulatory role of internet-supported mindfulness-based cognitive therapy, microfluidics-assisted methodology for CTC isolation, and proteogenomics in urine analysis for prostate cancer biomarkers. His research also delves into the DNA methylome and its implications for melanoma aggressiveness, as well as comprehensive metabolomics and lipidomics profiling in prostate cancer. Henrique's work is notable for integrating advanced techniques such as automatic text mining, genomic, and proteomic analyses to unravel cancer biomarkers.

Aliases

Rui Manuel Ferreira Henrique is known by several aliases including Rui Henrique, R.m. Henrique, Rui M.f. Henrique, Rui M Henrique, R Henrique, and R. Henrique.

Publication and Citation Metrics

Metric Value
Total Papers 388
Total Citations 11,237
h-index 56

Publications:

Partnered Content Networks

Relevant Topics